Repare Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Repare Therapeutics

02/03/2022 22:01

* Repare Therapeutics Inc  RPTX.OQ  reported a quarterly
adjusted
loss of 70 cents​​ per share for the quarter ended in December.
The mean expectation of eight analysts for the quarter was for a
loss of 74 cents per share.
    * Revenue rose 4,994.1% to $6.88 million from a year ago; 
analysts expected $3.28 million. 
    * Repare Therapeutics Inc's reported EPS for the quarter was
a
loss of 70 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Repare Therapeutics Inc shares had fallen by 23.9% this
quarter.
    * The company reported a quarterly loss of $28.29 million.
    * Wall Street's median 12-month price target for Repare
Therapeutics Inc is $45.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 2 at 10:00 p.m.  ​All
figures in US dollars unless otherwise stated